Dendritic cell subsets in health and disease

Summary:  The dendritic cell (DC) system of antigen‐presenting cells controls immunity and tolerance. DCs initiate and regulate immune responses in a manner that depends on signals they receive from microbes and their cellular environment. They allow the immune system to make qualitatively distinct responses against different microbial infections. DCs are composed of subsets that express different microbial receptors and express different surface molecules and cytokines. Our studies lead us to propose that interstitial (dermal) DCs preferentially activate humoral immunity, whereas Langerhans cells preferentially induce cellular immunity. Alterations of the DC system result in diseases such as autoimmunity, allergy, and cancer. Conversely, DCs can be exploited for vaccination, and novel vaccines that directly target DCs in vivo are being designed.

[1]  R. Steinman,et al.  IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE , 1973, The Journal of experimental medicine.

[2]  R. North,et al.  The murine antitumor immune response and its therapeutic manipulation. , 1984, Advances in immunology.

[3]  C. Jacob,et al.  Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.

[4]  H. Mcdevitt,et al.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. , 1988, Nature.

[5]  R. Zinkernagel,et al.  Deletion of self-reactive T cells before entry into the thymus medulla , 1988, Nature.

[6]  C. Janeway Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[7]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[8]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[9]  K. Öberg,et al.  Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment , 1991 .

[10]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[11]  P. Srivastava,et al.  Stress-induced proteins in immune response to cancer. , 1991, Current topics in microbiology and immunology.

[12]  K. Oberg,et al.  Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. , 1991, Acta oncologica.

[13]  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[14]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[15]  A. Enk,et al.  Identification and induction of keratinocyte-derived IL-10. , 1992, Journal of immunology.

[16]  J. Banchereau,et al.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. , 1992, Nature.

[17]  M. Moser,et al.  Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo , 1992, The Journal of experimental medicine.

[18]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[19]  R. Steinman,et al.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.

[20]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[21]  F. Nestle,et al.  Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. , 1994, The Journal of clinical investigation.

[22]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[23]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[24]  M. Mohamadzadeh,et al.  Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. , 1995, Journal of immunology.

[25]  R. Henderson,et al.  MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines , 1995, Immunological reviews.

[26]  Å. Lernmark,et al.  Interferon Expression in the Pancreases of Patients With Type I Diabetes , 1995, Diabetes.

[27]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[28]  G. Trinchieri,et al.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.

[29]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[30]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[31]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[32]  A. Enk,et al.  Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells , 1996, European journal of immunology.

[33]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[34]  J. Banchereau,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.

[35]  J. Banchereau,et al.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines , 1996, The Journal of experimental medicine.

[36]  R. Darnell Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Banchereau,et al.  Dendritic cells capable of stimulating T cells in germinal centres , 1996, Nature.

[38]  Edgar G. Engleman,et al.  Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.

[39]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[40]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[41]  J. Banchereau,et al.  Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells , 1997, The Journal of experimental medicine.

[42]  J. Banchereau,et al.  The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand , 1997, The Journal of experimental medicine.

[43]  A. Enk,et al.  Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions , 1997, European journal of immunology.

[44]  F. Lund-Johansen,et al.  Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C Caux,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. , 1997, Blood.

[46]  Christophe Caux,et al.  Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes , 1997, The Journal of experimental medicine.

[47]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[48]  R. Steinman,et al.  Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.

[49]  C. Rabourdin-Combe,et al.  Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells , 1997, The Journal of experimental medicine.

[50]  J. Banchereau,et al.  Human Dendritic Cells Skew Isotype Switching of CD40-activated Naive B Cells towards IgA1 and IgA2 , 1997, The Journal of experimental medicine.

[51]  A. Enk,et al.  Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma , 1997, International journal of cancer.

[52]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[53]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[54]  J. Banchereau,et al.  Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. , 1998, Journal of immunology.

[55]  K. Toellner,et al.  CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1 , 1998, The Journal of experimental medicine.

[56]  K. Pang,et al.  Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.

[57]  A. Pombo,et al.  Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. , 1998, Journal of immunology.

[58]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[59]  O. Majdic,et al.  Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. , 1998, Journal of immunology.

[60]  C Caux,et al.  The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. , 1998, Journal of immunology.

[61]  F. Spertini,et al.  Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers , 1999, Journal of Neuroimmunology.

[62]  A. Enk,et al.  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. , 1999, Blood.

[63]  Sejal Patel,et al.  APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. , 1999, Journal of immunology.

[64]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[65]  J. Cyster,et al.  Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.

[66]  R. Steinman,et al.  Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. , 1999, The Journal of clinical investigation.

[67]  Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. , 1999, Blood.

[68]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[69]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.

[70]  J. Cyster,et al.  Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. , 1999, Science.

[71]  A. Enk,et al.  Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma , 1999, The Journal of experimental medicine.

[72]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[73]  J. Banchereau,et al.  In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas , 1999, The Journal of experimental medicine.

[74]  A. Lanzavecchia,et al.  Inhibition of dendritic cell maturation by herpes simplex virus , 1999, European journal of immunology.

[75]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[76]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[77]  H. Fujiwara,et al.  A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. , 1999, Journal of immunology.

[78]  H. Fujiwara,et al.  A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System , 1999, The Journal of Immunology.

[79]  C. Takahashi,et al.  Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. , 1999, Journal of immunology.

[80]  T. Ito,et al.  A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. , 1999, Journal of immunology.

[81]  P. Ricciardi-Castagnoli,et al.  Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo , 1999, Nature Medicine.

[82]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[83]  P. Allavena,et al.  Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.

[84]  B. Pulendran,et al.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.

[85]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[86]  Simon C Watkins,et al.  The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells1 , 2000, The Journal of Immunology.

[87]  T. Schumacher,et al.  CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.

[88]  J. D. de Fijter,et al.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. , 2000, European journal of immunology.

[89]  J. Davoust,et al.  Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. , 2000, Immunity.

[90]  Nina Bhardwaj,et al.  Consequences of cell death: exposure to necrotic tumor cells , 2000 .

[91]  A. Lanzavecchia,et al.  Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization , 2000, Nature Immunology.

[92]  B. Blom,et al.  Generation of Interferon α–Producing Predendritic Cell (Pre-Dc)2 from Human Cd34+ Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[93]  J. Banchereau,et al.  Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1 , 2000, The Journal of Immunology.

[94]  Carl G. Figdor,et al.  DC-SIGN–ICAM-2 interaction mediates dendritic cell trafficking , 2000, Nature Immunology.

[95]  E. Clark,et al.  Characterization of Human Inducible Costimulator Ligand Expression and Function1 , 2000, The Journal of Immunology.

[96]  Douglas S Kwon,et al.  DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.

[97]  T. Di Pucchio,et al.  Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid Mice , 2000, The Journal of experimental medicine.

[98]  J. Darnell,et al.  Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. , 2000, Cancer research.

[99]  R. Steinman,et al.  Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. , 2000, The Journal of clinical investigation.

[100]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[101]  J. Banchereau,et al.  IL-6 switches the differentiation of monocytes from dendritic cells to macrophages , 2000, Nature Immunology.

[102]  H. Ploegh,et al.  Viral subversion of the immune system. , 2000, Annual review of immunology.

[103]  P. Ricciardi-Castagnoli,et al.  Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans , 2000, The Journal of experimental medicine.

[104]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[105]  C. Figdor,et al.  Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.

[106]  P. Allavena,et al.  The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues , 2000, Immunological reviews.

[107]  C. Maliszewski,et al.  In vivo generation of human dendritic cell subsets by Flt3 ligand. , 2000, Blood.

[108]  M. Peshwa,et al.  Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  Antonio Lanzavecchia,et al.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.

[110]  Antonio Lanzavecchia,et al.  BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction , 2001, The Journal of experimental medicine.

[111]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[112]  F. Gheyas,et al.  Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.

[113]  Maria Persico,et al.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis , 2001, Nature Immunology.

[114]  T. Di Pucchio,et al.  Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. , 2001, Blood.

[115]  J. Banchereau,et al.  Sensing Pathogens and Tuning Immune Responses , 2001, Science.

[116]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[117]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[118]  J. Pin,et al.  Immature Human Dendritic Cells Express Asialoglycoprotein Receptor Isoforms for Efficient Receptor-Mediated Endocytosis1 , 2001, The Journal of Immunology.

[119]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[120]  Bali Pulendran,et al.  Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo1 , 2001, The Journal of Immunology.

[121]  L Meyer,et al.  Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. , 2001, Blood.

[122]  B. Redman,et al.  Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. , 2001, Cancer research.

[123]  D. Carbone,et al.  VEGF as a mediator of tumor-associated immunodeficiency , 2001, Immunologic research.

[124]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[125]  V. Pascual,et al.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.

[126]  R. Steinman,et al.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.

[127]  Jerome F. Strauss,et al.  The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[128]  X. Cao,et al.  The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells. , 2001, Journal of immunology.

[129]  R. Crystal,et al.  Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors. , 2001, Cancer research.

[130]  Xuetao Cao,et al.  The Involvement of TNF-α-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-β-Stimulated Human Dendritic Cells to Tumor Cells1 , 2001, The Journal of Immunology.

[131]  Mark M. Davis,et al.  Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[132]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[133]  Virginia Pascual,et al.  Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.

[134]  M. Raftery,et al.  Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. , 2001, Immunity.

[135]  F. Belardelli,et al.  IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation1 , 2001, The Journal of Immunology.

[136]  Angel Porgador,et al.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.

[137]  J. Banchereau,et al.  Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells , 2001, The Journal of experimental medicine.

[138]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[139]  R. Steinman,et al.  Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs , 2002, Nature Immunology.

[140]  G. Schuler,et al.  Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells , 2002, The Journal of experimental medicine.

[141]  Kayo Nakamura,et al.  Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. , 2002, Immunity.

[142]  C. Figdor,et al.  C-type lectin receptors on dendritic cells and langerhans cells , 2002, Nature Reviews Immunology.

[143]  R. Steinman,et al.  Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. , 2002, Blood.

[144]  L. Kwak,et al.  Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. , 2002, Science.

[145]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[146]  M. Smyth,et al.  NKT cells - conductors of tumor immunity? , 2002, Current opinion in immunology.

[147]  B. Nardelli,et al.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL , 2002, Nature Immunology.

[148]  T. Whiteside,et al.  Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway1 , 2002, The Journal of Immunology.

[149]  T. Ahrens,et al.  Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.

[150]  L. Kwak,et al.  Mammalian defensins in immunity: more than just microbicidal. , 2002, Trends in immunology.

[151]  M. Gilliet,et al.  Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells , 2002, The Journal of experimental medicine.

[152]  K. MacDonald,et al.  Characterization of human blood dendritic cell subsets. , 2002, Blood.

[153]  F. Brière,et al.  Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. , 2002, Blood.

[154]  L. Adorini,et al.  Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. , 2002, Human immunology.

[155]  J. Kearney,et al.  Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. , 2002, Immunity.

[156]  T. Whiteside,et al.  Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand1 , 2002, The Journal of Immunology.

[157]  D. Lipsker,et al.  Endotoxin‐free heat‐shock protein 70 fails to induce APC activation , 2002, European journal of immunology.

[158]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[159]  V. Pascual,et al.  Blood dendritic cells and DC-poietins in systemic lupus erythematosus. , 2002, Human immunology.

[160]  G. Trinchieri,et al.  Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells , 2002, The Journal of experimental medicine.

[161]  Giovanni Melioli,et al.  Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells , 2002, The Journal of experimental medicine.

[162]  C. Caux,et al.  Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces , 2002, European journal of immunology.

[163]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[164]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[165]  M. Fortini,et al.  Signalling: γ-Secretase-mediated proteolysis in cell-surface-receptor signalling , 2002, Nature Reviews Molecular Cell Biology.

[166]  Kouji Matsushima,et al.  Pivotal Role of Dendritic Cell–derived CXCL10 in the Retention of T Helper Cell 1 Lymphocytes in Secondary Lymph Nodes , 2002, The Journal of experimental medicine.

[167]  G. Berry,et al.  Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity , 2002, Nature Medicine.

[168]  M. Brenner,et al.  CD1-mediated γ/δ T Cell Maturation of Dendritic Cells , 2002, The Journal of experimental medicine.

[169]  J. Mulé,et al.  Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[170]  R. Steinman,et al.  Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. , 2002, Nature immunology.

[171]  C. Bogdan,et al.  Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity , 2002, The Journal of experimental medicine.

[172]  T. Whiteside,et al.  Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. , 2002, Journal of immunology.

[173]  I. Salmon,et al.  Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. , 2002, Blood.

[174]  Hugues Lortat-Jacob,et al.  Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. , 2002, Immunity.

[175]  Eric P. Hoffman,et al.  Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 , 2002, The Journal of Immunology.

[176]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[177]  A. Harris,et al.  NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells 1 , 2003, The Journal of Immunology.

[178]  Lukas Hunziker,et al.  Dendritic cell–induced autoimmune heart failure requires cooperation between adaptive and innate immunity , 2003, Nature Medicine.

[179]  R. Steinman,et al.  Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells , 2003, The Journal of experimental medicine.

[180]  V. Engelhard,et al.  Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control , 2003, The Journal of experimental medicine.

[181]  A. Aguzzi,et al.  Dangerous Liaisons between a Microbe and the Prion Protein , 2003, The Journal of experimental medicine.

[182]  A. Rudensky,et al.  Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. , 2003, Immunity.

[183]  G. Trinchieri,et al.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. , 2003, Immunity.

[184]  P. Sly,et al.  Bidirectional Interactions between Antigen-bearing Respiratory Tract Dendritic Cells (DCs) and T Cells Precede the Late Phase Reaction in Experimental Asthma , 2003, The Journal of experimental medicine.

[185]  D. Olive,et al.  IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. , 2003, Journal of immunology.

[186]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[187]  A. Palucka,et al.  TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells 1 , 2003, The Journal of Immunology.

[188]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[189]  M. Tsan,et al.  Endotoxin Contamination in Recombinant Human Heat Shock Protein 70 (Hsp70) Preparation Is Responsible for the Induction of Tumor Necrosis Factor α Release by Murine Macrophages* , 2003, The Journal of Biological Chemistry.

[190]  M. Feldmann,et al.  Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. , 2003, Nature medicine.

[191]  S. Akira,et al.  The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.

[192]  A. Yamamoto,et al.  Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells , 2003, The Journal of Immunology.

[193]  D. Choubey,et al.  Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice , 2003, The Journal of experimental medicine.

[194]  M. Moser Dendritic cells in immunity and tolerance-do they display opposite functions? , 2003, Immunity.

[195]  U. V. von Andrian,et al.  Chemokine regulation of naïve T cell traffic in health and disease. , 2003, Seminars in immunology.

[196]  H. Hammad,et al.  Taking our breath away: dendritic cells in the pathogenesis of asthma , 2003, Nature Reviews Immunology.

[197]  Annalisa Capobianco,et al.  Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells , 2003, The Journal of Immunology.

[198]  B. Fox,et al.  Anti‐tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution , 2003, European journal of immunology.

[199]  Bali Pulendran,et al.  Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin , 2003, Nature.

[200]  M. Kubo,et al.  Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. , 2003, Immunity.

[201]  O. Schwartz,et al.  DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2* , 2003, Journal of Biological Chemistry.

[202]  M. Kapsenberg Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.

[203]  Wolfgang Weninger,et al.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells , 2003, Nature.

[204]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[205]  J. Demengeot,et al.  Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. , 2003, Journal of autoimmunity.

[206]  R. Doms,et al.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. , 2003, Virology.

[207]  F. Siegal,et al.  Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration , 2003, Lupus.

[208]  D. Mancini,et al.  High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. , 2003, Transplant immunology.

[209]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[210]  Virginia Pascual,et al.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. , 2003, Immunity.

[211]  H. Hammad,et al.  Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled Antigen , 2004, The Journal of experimental medicine.

[212]  J. Connolly,et al.  Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules , 2004, The Journal of Immunology.

[213]  K. Rock,et al.  Natural endogenous adjuvants , 2004, Springer Seminars in Immunopathology.

[214]  H. Smits,et al.  Commensal Gram‐negative bacteria prime human dendritic cells for enhanced IL‐23 and IL‐27 expression and enhanced Th1 development , 2004, European journal of immunology.

[215]  Si-young Song,et al.  Retinoic acid imprints gut-homing specificity on T cells. , 2004, Immunity.

[216]  J. Berzofsky,et al.  Progress on new vaccine strategies for the immunotherapy and prevention of cancer. , 2004, The Journal of clinical investigation.

[217]  T. Rowley,et al.  Cutting Edge: A Critical Role for CD70 in CD8 T Cell Priming by CD40-Licensed APCs1 , 2004, The Journal of Immunology.

[218]  L. Thomsen,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. , 2004, Nature immunology.

[219]  D. Pardoll,et al.  Cancer immunotherapy: breaking the barriers to harvest the crop , 2004, Nature Medicine.

[220]  S. Akira,et al.  Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes , 2004, The Journal of experimental medicine.

[221]  Christine Trumpfheller,et al.  HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[222]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[223]  J. Kirkwood,et al.  alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. , 2004, Cancer research.

[224]  S. Ho,et al.  Human thymic stromal lymphopoietin promotes dendritic cell–mediated CD4+ T cell homeostatic expansion , 2004, Nature Immunology.

[225]  H. Harizi,et al.  Prostanoids and their receptors that modulate dendritic cell‐mediated immunity , 2004, Immunology and cell biology.

[226]  D. Gabrilovich Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[227]  S. Gordon,et al.  Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes* , 2004, Journal of Biological Chemistry.

[228]  P. Srivastava,et al.  The heat-shock protein receptors: some answers and more questions. , 2004, Tissue antigens.

[229]  B. Blom,et al.  Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. , 2004, Blood.

[230]  T. Geijtenbeek,et al.  Self- and nonself-recognition by C-type lectins on dendritic cells. , 2004, Annual review of immunology.

[231]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[232]  R. Steinman,et al.  In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination , 2004, The Journal of experimental medicine.

[233]  F. Martinon,et al.  Inflammatory Caspases Linking an Intracellular Innate Immune System to Autoinflammatory Diseases , 2004, Cell.

[234]  A. Spurkland,et al.  Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex , 2004, Immunogenetics.

[235]  C. Gianfrani,et al.  IL‐10‐Producing T Regulatory Type 1 Cells and Oral Tolerance , 2004, Annals of the New York Academy of Sciences.

[236]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.

[237]  V. Pascual,et al.  Autoimmunity through cytokine-induced dendritic cell activation. , 2004, Immunity.

[238]  T. Watts,et al.  Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[239]  R. Steinman,et al.  CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[240]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[241]  K. Matsushima,et al.  Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. , 2004, International immunology.

[242]  T. Schumacher,et al.  Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation , 2004, The Journal of experimental medicine.

[243]  A. Vlad,et al.  MUC1 immunobiology: from discovery to clinical applications. , 2004, Advances in immunology.

[244]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[245]  J. Banchereau,et al.  Dendritic cells generated in the presence of GM‐CSF plus IL‐15 prime potent CD8+ Tc1 responses in vivo , 2004, European journal of immunology.

[246]  Henry C. Chang,et al.  Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.

[247]  Steven A Greenberg,et al.  Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. , 2005, Annals of neurology.

[248]  V. Pascual,et al.  Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[249]  F. Poccia,et al.  Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated γδ T Cells: Role of CD86 and Inflammatory Cytokines1 , 2005, The Journal of Immunology.

[250]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[251]  Francesco Bertoni,et al.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells , 2005, Nature Immunology.

[252]  S. Ziegler,et al.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin , 2005, The Journal of experimental medicine.

[253]  Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients , 2005, The Journal of experimental medicine.

[254]  James W. Young,et al.  Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. , 2005, Blood.

[255]  J. Banchereau,et al.  IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. , 2005, Journal of immunology.

[256]  J. Ravetch,et al.  Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. , 2005, The Journal of clinical investigation.

[257]  F. Poccia,et al.  Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. , 2005, Journal of immunology.

[258]  P. Verginis,et al.  Tolerogenic Semimature Dendritic Cells Suppress Experimental Autoimmune Thyroiditis by Activation of Thyroglobulin-Specific CD4+CD25+ T Cells1 , 2005, The Journal of Immunology.

[259]  O. Boyman,et al.  Plasmacytoid predendritic cells initiate psoriasis through interferon-α production , 2005, The Journal of experimental medicine.

[260]  Hua Yu,et al.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity , 2005, Nature Medicine.

[261]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[262]  T. Geijtenbeek,et al.  Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN , 2005, The Journal of experimental medicine.

[263]  P. Roholl,et al.  Respiratory Syncytial Virus Infection of Monocyte-Derived Dendritic Cells Decreases Their Capacity to Activate CD4 T Cells , 2005, The Journal of Immunology.

[264]  S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[265]  M. Nussenzweig,et al.  Inducing and expanding regulatory T cell populations by foreign antigen , 2005, Nature Immunology.

[266]  F. Hanisch,et al.  Human Tumor Antigen MUC1 Is Chemotactic for Immature Dendritic Cells and Elicits Maturation but Does Not Promote Th1 Type Immunity 1 , 2005, The Journal of Immunology.

[267]  P. Perrin,et al.  Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.

[268]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[269]  D. Philpott,et al.  Synergistic stimulation of human monocytes and dendritic cells by Toll‐like receptor 4 and NOD1‐ and NOD2‐activating agonists , 2005, European journal of immunology.

[270]  H. D. Liggitt,et al.  Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice , 2005, Nature Immunology.

[271]  J. Moreau,et al.  Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[272]  C. Figdor,et al.  Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. , 2005, Blood.

[273]  S. Saeland,et al.  Cutaneous dendritic cells. , 2005, Seminars in immunology.

[274]  J. Banchereau,et al.  IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1 , 2005, The Journal of Immunology.

[275]  J. Ting,et al.  CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.

[276]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[277]  S. Kim-Schulze,et al.  Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. , 2005, International immunopharmacology.

[278]  V. Pascual,et al.  Cross-regulation of TNF and IFN-alpha in autoimmune diseases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[279]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.

[280]  G. Pinkus,et al.  Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis , 2005 .

[281]  V. Pascual,et al.  Dendritic cells control B cell growth and differentiation. , 2005, Current directions in autoimmunity.

[282]  J. Banchereau,et al.  Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. , 2005, The Journal of infectious diseases.

[283]  S. Akira,et al.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[284]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[285]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[286]  O. Schneewind,et al.  Plague Bacteria Target Immune Cells During Infection , 2005, Science.

[287]  Wenru Song,et al.  Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells. , 2005, Cancer research.

[288]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[289]  R. Steinman,et al.  Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[290]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[291]  J. Mora,et al.  Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues , 2005, The Journal of experimental medicine.

[292]  A. Luster,et al.  Toll‐Like Receptor Activation in the Pathogenesis of Systemic Lupus Erythematosus , 2005, Annals of the New York Academy of Sciences.

[293]  M. Willart,et al.  In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma , 2005, The Journal of experimental medicine.

[294]  Yu Wang,et al.  Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus , 2005, Nature.

[295]  R. Steinman,et al.  Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[296]  L. Zitvogel,et al.  Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death , 2005, The Journal of experimental medicine.

[297]  Yu Wang,et al.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.

[298]  J. A. Lopez,et al.  Dendritic cell dysfunction in cancer: A mechanism for immunosuppression , 2005, Immunology and cell biology.

[299]  F. Martinon,et al.  NLRs join TLRs as innate sensors of pathogens. , 2005, Trends in immunology.

[300]  R. Clynes,et al.  Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. , 2005, Immunity.

[301]  V. Pascual,et al.  Cross-regulation of TNF and IFN-¿ in autoimmune diseases , 2005 .

[302]  M. Zenke,et al.  Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. , 2005, The Journal of general virology.

[303]  M. Nussenzweig,et al.  The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites , 2006, Nature.

[304]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[305]  R. Steinman,et al.  Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine , 2006, The Journal of experimental medicine.

[306]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[307]  L. Hennighausen,et al.  Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.

[308]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[309]  M. Gilliet,et al.  OX40 ligand shuts down IL-10-producing regulatory T cells , 2006, Proceedings of the National Academy of Sciences.

[310]  Katsuaki Sato,et al.  Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. , 2006, Blood.

[311]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[312]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[313]  S. Akira,et al.  U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. , 2006, Blood.

[314]  A. Satterthwaite,et al.  Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication , 2006, Science.

[315]  P. Opolon,et al.  A novel dendritic cell subset involved in tumor immunosurveillance , 2006, Nature Medicine.

[316]  M. Idzko,et al.  Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. , 2006, The Journal of clinical investigation.

[317]  H. Ueno,et al.  Dendritic Cells Loaded With Killed Allogeneic Melanoma Cells can Induce Objective Clinical Responses and MART-1 Specific CD8+ T-cell Immunity , 2006, Journal of immunotherapy.

[318]  Y. van Kooyk,et al.  Recognition of tumor glycans by antigen-presenting cells. , 2006, Current opinion in immunology.

[319]  J. Connolly,et al.  Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. , 2006, Blood.

[320]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[321]  C. Lucchesi,et al.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[322]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[323]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[324]  R. Coffman,et al.  Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation , 2006, The Journal of experimental medicine.

[325]  L Edler,et al.  Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[326]  T. Geijtenbeek,et al.  Two way communication between neutrophils and dendritic cells. , 2006, Current opinion in pharmacology.

[327]  C. J. Barnes,et al.  Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. , 2006, Immunity.

[328]  S. Quezada,et al.  Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. , 2006, Current opinion in immunology.

[329]  P. Wallace,et al.  Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells , 2007, Journal of Translational Medicine.

[330]  D. Danilenko,et al.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells , 2006, Nature Immunology.

[331]  R. Steinman,et al.  Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. , 2006, Blood.

[332]  Gordon D. Brown Dectin-1: a signalling non-TLR pattern-recognition receptor , 2006, Nature Reviews Immunology.

[333]  B. Finlay,et al.  Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens , 2006, Cell.

[334]  C. Caux,et al.  Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria1 , 2006, The Journal of Immunology.

[335]  Steffen Jung,et al.  The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity , 2006, European journal of immunology.

[336]  F. Powrie,et al.  Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.

[337]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[338]  D. Isenberg,et al.  Systemic lupus erythematosus—2005 annus mirabilis? , 2006, Nature Clinical Practice Rheumatology.

[339]  L. Lanier,et al.  Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity , 2006, Nature Medicine.

[340]  S. Jagannath,et al.  Enhancement of clonogenicity of human multiple myeloma by dendritic cells , 2006, The Journal of experimental medicine.

[341]  Ronald N. Germain,et al.  Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells , 2006, Science.

[342]  V. Pascual,et al.  Persistent expression of autoantibodies in SLE patients in remission , 2006, The Journal of experimental medicine.

[343]  Y. Kooyk,et al.  Langerin is a natural barrier to HIV-1 transmission by Langerhans cells , 2007, Nature Medicine.

[344]  M. Idzko,et al.  Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. , 2007, The Journal of clinical investigation.

[345]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[346]  B. Bogen,et al.  Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors1 , 2007, The Journal of Immunology.

[347]  N. Kanazawa Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells. , 2007, Journal of dermatological science.

[348]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[349]  G. Rabinovich,et al.  Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.

[350]  R. Steinman,et al.  Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice , 2007, The Journal of experimental medicine.

[351]  X. Sastre,et al.  Cutting Edge: Proinflammatory and Th2 Cytokines Synergize to Induce Thymic Stromal Lymphopoietin Production by Human Skin Keratinocytes1 , 2007, The Journal of Immunology.

[352]  H. Yagita,et al.  Priming of CD8+ T cell responses by pathogens typically depends on CD70‐mediated interactions with dendritic cells , 2007, European journal of immunology.

[353]  H. Hase,et al.  TACI regulates IgA production by APRIL in collaboration with HSPG. , 2007, Blood.

[354]  M. O’Riordan,et al.  Innate recognition of intracellular bacteria. , 2007, Current opinion in immunology.

[355]  X. Qin,et al.  Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand , 2007, The Journal of experimental medicine.

[356]  S. Jagannath,et al.  Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. , 2007, Blood.

[357]  J. Bos,et al.  Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition1 , 2007, The Journal of Immunology.

[358]  Junliang Pan,et al.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.

[359]  Tomoki Ito,et al.  TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.

[360]  J. Tschopp,et al.  A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.

[361]  H. Hammad,et al.  Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells , 2007, The Journal of experimental medicine.

[362]  S. Mariathasan,et al.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.

[363]  A. Rudensky,et al.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice , 2007, Nature Immunology.

[364]  C. Aspord,et al.  Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development , 2007, The Journal of experimental medicine.

[365]  R. Steinman,et al.  A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo , 2007, The Journal of experimental medicine.

[366]  A. Diefenbach,et al.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15. , 2007, Immunity.

[367]  R. Kastelein,et al.  Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. , 2007, Annual review of immunology.

[368]  John E. Connolly,et al.  IL‐15‐induced human DC efficiently prime melanoma‐specific naive CD8+ T cells to differentiate into CTL , 2007, European journal of immunology.

[369]  M. Carrington,et al.  DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes , 2007, Proceedings of the National Academy of Sciences.

[370]  Franco Patrone,et al.  The use of dendritic cells in cancer immunotherapy. , 2008, Critical reviews in oncology/hematology.

[371]  D. Isenberg,et al.  Systemic lupus erythematosus. , 2008, The New England journal of medicine.